Home / 600223.SS : SHH

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does 600223.SS make money? Does 600223.SS have pricing power? What's the Earnings Whisper? Will 600223.SS profit more as the business scales? What is 600223.SS's management track record? Is 600223.SS's current price justified?

Lushang Freda Pharmaceutical Co.,Ltd.

¥5.61 -$1.79 (-24.19%)

SHH · 16 Oct 2026 07:00 UTC

Previous Close

¥5.63

Day Range

¥5.57¥5.76

Year Range

¥4.89¥8.37

Market Cap

5.7B

AVG Volume

8.64M

Trailing/Forward PE

35.6/24.04

PEG ratio

-1.66

Dividend Yield

1.02%

Next Earnings Date

2026-10-28

Primary Exchange

Shanghai Stock Exchange

Revenue (CNY) · A

600223.SS Revenue (CNY) by year
Period	Revenue (CNY)
2025	3.65B
2024	3.98B
2023	4.58B
2022	12.95B
2021	12.36B
2020	13.62B
2019	10.29B
2018	8.82B
2017	8.29B
2016	7.65B

Net Income (CNY) · A

600223.SS Net Income (CNY) by year
Period	Net Income (CNY)
2025	187.75M
2024	243.53M
2023	303.39M
2022	45.46M
2021	361.9M
2020	638.67M
2019	344.51M
2018	162.06M
2017	128.07M
2016	92.37M

Operating Income (CNY) · A

600223.SS Operating Income (CNY) by year
Period	Operating Income (CNY)
2025	225.41M
2024	337.83M
2023	419.45M
2022	310.85M
2021	677.67M
2020	875.4M
2019	574.15M
2018	471.11M
2017	349.31M
2016	223.92M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (CNY) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Lushang Freda Pharmaceutical Co.,Ltd.

Video analysis: 600223.SS

News: 600223.SS

Similar companies